Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06711055

Recruiting

Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer (TaxHER)

HER2-positive Breast Cancer
NCT06586047

Recruiting

Breast Cancer PSMA PET

Triple Negative Breast Cancer
NCT06547853

Recruiting

Physical and Health Outcomes With ExeRcise in Cancer SURVIVORS (POWERSurviv)

Exercise | Breast Cancer Female
NCT06528808

Not yet recruiting

Simple Simulation Based Breast Cancer Awareness Training

Breast Cancer Awareness Training
NCT06489821

Not yet recruiting

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer (STAR-B)

Metastatic Breast Cancer | Oligoprogression
NCT06375798

Recruiting

Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer

Breast Cancer | HER2-negative Breast Cancer
NCT06161922

Recruiting

Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy

HER2-positive Breast Cancer
NCT05912062

Recruiting

Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer (BiOnHER)

Neoplasms | Breast Cancer | HER2-positive Breast Cancer
NCT05837455

Recruiting

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Breast Cancer | Cancer of the Breast
NCT05561686

Not yet recruiting

Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

HER2-positive Breast Cancer
NCT05466786

Recruiting

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

Breast Cancer | HER2-low Breast Cancer
NCT05406232

Recruiting

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Breast Carcinoma | Invasive Breast Carcinoma
NCT05386719

Recruiting

Cardiometabolic Screening Program

Breast Cancer | Early-stage Breast Cancer
NCT05378464

Recruiting

Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

HER2-positive Breast Cancer
NCT05345860

Recruiting

Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer (AMENDER)

Early-stage Breast Cancer
NCT05346107

Recruiting

PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer
NCT05334810

Not yet recruiting

DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer

HER2-positive Breast Cancer
NCT05332561

Recruiting

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Early-stage Breast Cancer
NCT05325632

Recruiting

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

HER2-positive Breast Cancer
NCT05154396

Not yet recruiting

Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer

HER2-positive Breast Cancer
NCT05033925

Recruiting

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

Breast Cancer Stage IV
NCT04624711

Recruiting

Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer

HER2-negative Breast Cancer
NCT04547907

Recruiting

A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Breast Cancer,HER2-positive
NCT04360330

Recruiting

SABER Study for Selected Early Stage Breast Cancer (SABER)

Breast Cancer | Early-stage Breast Cancer
NCT03655353

Recruiting

A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer (Affibody-3)

HER2-positive Breast Cancer
NCT03238495

Recruiting

Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer (HERMET)

HER2-positive Breast Cancer
NCT05203445

Active, not recruiting

A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Breast Cancer
NCT04568616

Active, not recruiting

Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NAOMI)

Breast Cancer | ER Positive Breast Cancer
NCT05296746

Active, not recruiting

Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer (RIBOLARIS)

Breast Cancer Stage II
NCT03738553

Terminated

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

HER2-positive Breast Cancer
NCT05132582

Active, not recruiting

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)

HER2 Positive Breast Cancer
NCT04208178

Active, not recruiting

Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation (EPIK-B2)

Advanced HER2+Breast Cancer
NCT02348684

Completed

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

Node Positive Breast Cancer
NCT05852691

Active, not recruiting

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

Breast Cancer
NCT01928589

Active, not recruiting

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Breast Cancer | Adenocarcinoma of the Breast
NCT01597388

Completed

AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

Advanced Metastatic Breast Cancer
NCT04273555

Withdrawn

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

HER2-positive Breast Cancer
NCT04188119

Withdrawn

A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer (IMpALA)

Breast Cancer
NCT03414684

Active, not recruiting

Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

Breast Cancer
NCT05339685

Active, not recruiting

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Breast Cancer
NCT06125314

Completed

HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council

Breast Cancer | Breast Neoplasms | Breast Carcinoma | Genes | HER2
NCT02889874

Active, not recruiting

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT)

Early Stage Breast Carcinoma
NCT07143097

Completed

Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer

Triple -Negative Breast Cancer
NCT07130643

Active, not recruiting

Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer

HR+/HER2- Breast Cancer
NCT06833268

Completed

Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

HER2-positive Breast Cancer
NCT04711109

Active, not recruiting

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation (BRCA-P)

Neoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 Mutation
NCT03989089

Active, not recruiting

Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation

HER2-Negative Breast Cancer
NCT02214381

Completed

A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

Early Primary Breast Cancer
NCT04588298

Completed

A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer (SERENA-3)

HER2-negative Breast Cancer
NCT02167490

Active, not recruiting

Sentinel Node Vs Observation After Axillary Ultra-souND (SOUND)

Early Stage Breast Carcinoma

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations